CancerCare's free Connect Education Workshops are a way for people to learn about cancer-related issues from the convenience of their home or office. Leading experts in oncology provide the most up-to-date information in these workshops to help you and your loved ones better understand and cope with your cancer diagnosis, treatment options, quality-of-life concerns, treatment side effects, pain management, doctor-patient communication and other important topics.
…
continue reading
Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Clinical Care Options. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.
…
continue reading
Sarcoma UK Support Line * 0808 801 0401 * [email protected] We’re here to make sure that everyone diagnosed with sarcoma gets the information and support they need to move forward. Together, we’re funding research, raising awareness, and pushing for policy changes that will improve access to treatment for everyone affected by this uncommon disease. To find out how to donate, fundraise or volunteer for Sarcoma UK, visit sarcoma.org.uk
…
continue reading
The SCT Hour covers all things related to Sarcoma at the Royal National Orthopaedic Hospital, hosted by Sarah Wright, Head of Fundraising at the Skeletal Cancer Trust. Including interviews with fundraisers and supporters, as well as physiotherapists and surgeons who work at the RNOH. We will also feature highlights from some of our fundraising events.
…
continue reading
Featuring one-on-one discussions with leading oncology investigators, this series assists clinicians with the formulation of up-to-date clinical management strategies so that they can provide optimal care for patients with melanoma and nonmelanoma skin cancer.
…
continue reading
The Journal of Clinical Oncology podcast, hosted by Dr. Shannon Westin and Dr. Davide Soldato, presents analyses and discussions centered on the latest findings published in ASCO’s esteemed Journal of Clinical Oncology. Through scholarly discourse and examination, this podcast is your resource for navigating oncological advancements and how they impact clinical practice. The JCO Podcast also features in depth summaries and interviews hosted by the year’s fellows in the series, JCO Article In ...
…
continue reading
Wait How Do You Spell That? is a rare disease podcast produced by Patient Worthy. We talk about issues affecting people rare and underdiagnosed conditions and interview advocates from across the community. We‘re definitely not doctors, and we can‘t give you medical advice. We‘re just here to chat and learn about the diseases that even doctors can‘t seem to spell. Check out the latest in rare disease news at PatientWorthy.com.
…
continue reading
The Oncology Podcast including The Oncology Journal Club Podcast by Professor Craig Underhill, Dr Kate Clarke and Professor Christopher Jackson; and Supportive Care Matters by Dr. Bogda Koczwara. Oncology News and Expert Analysis from a unique Australian viewpoint. Proudly brought to you by The Oncology Network. The Oncology Network are producers of digital resources that support busy oncology health professionals. For more information visit our website www.oncologynetwork.com.au. We also in ...
…
continue reading
As the leading authoritative, peer-reviewed audio source of oncology clinical news for clinicians and healthcare professionals, the AJO Podcast regularly brings you exclusive interviews with the world's leading researchers and clinicians responsible for pushing out the boundaries of science and practice. Medicine, screening, radiotherapy, surgery, clinical trials, cancer care, epidemiology and prevention are covered impartially to give busy cancer professionals access to conversational spoke ...
…
continue reading
Oncology nurses Anne-Marie Fay & Michelle Matthews interview leading consultants to provide a better understanding of Cancer
…
continue reading
A journal club podcast with Joe Cuevas, Kelsey McCoy, & Tyler Burch. Join us as we delve into the publically-available world of science and learn a little in the process.
…
continue reading
Inspiring stories of resilience from cancer patients, survivors, and family members. www.sockswithstories.com
…
continue reading
Physicians' Education Resource® (PER®) is committed to advancing patient care through professional education. This podcast is a natural extension of PER®'s efforts to provide medical education for health care providers to stay up to date with advances in medical care, from diagnosis through treatment, with the ultimate goal of improving patient outcomes. Visit http://www.gotoper.com for more information.
…
continue reading
A podcast dedicated to providing an accurate and alternate narrative to the public regarding the necessity of humane and ethical animal research. Lab Rat Chat was made possible through the Michael D. Hayre Fellowship in Public Outreach, which is sponsored by the biomedical research advocacy group Americans for Medical Progress.
…
continue reading

1
Cancer Healing Journeys by ZenOnco.io & Love Heals Cancer
Kishan Shah, Vasundhara Raghavan, Nadia Raju, Prabhat Kumar Verma, Imran Shaikh, Vijay Sharnangat, Premitha R, Shreshtha Mittal, Divya Sharma, Bhumi Ben, Divya Par, Farida Rizwan, Asmita Bhattacharya, Sidharth Ghosh
"In life, winning and losing will both happen. What is never acceptable is quitting." When you feel that you are alone in this journey, you really are not alone. There are countless warriors who have gone through a similar journey like what you are going through today; they have felt the immense pain that you are experiencing; but in the end, they have healed themselves from cancer. Some talk about their own journey as you are listening to this, while some have defeated pain forever, but in ...
…
continue reading

1
Fast, Accurate Artificial Intelligence Method to Diagnose and Classify Pediatric Sarcoma Anywhere
15:56
15:56
Play later
Play later
Lists
Like
Liked
15:56An interview with: Adam Thiesen, PhD Candidate, UConn Health, University of Connecticut and the Jackson Laboratory for Genomic Medicine, Farmington, CT And with: Jayesh Desai MD, Medical Oncologist, Associate Director Clinical Research, Peter MacCallum Cancer Centre, Melbourne, Australia, Co-Chair, AACR Clinical Committee. CHICAGO – An artificial i…
…
continue reading

1
Understanding the Cost of Care & Your Health Care Coverage
1:00:33
1:00:33
Play later
Play later
Lists
Like
Liked
1:00:33- Overview of the Medical & Indirect Costs of Treatment- What to Do When Cancer Treatment Seems Unaffordable – Self Advocacy- Talking with Your Health Care Team about Your Financial Concerns- The Benefits & Limitations of Your Health Plans, Insurance, Medicare & Medicaid Coverage- Tips on Appealing Your Insurance & Medicare Claims & Provider Denial…
…
continue reading

1
Sarcoma and Other Connective Tissue Neoplasms — Fourth Annual National General Medical Oncology Summit
51:15
51:15
Play later
Play later
Lists
Like
Liked
51:15Clinical investigators discuss available data guiding the management of sarcoma and other connective tissue neoplasms. CME information and select publications here.By Dr. Neil Love
…
continue reading

1
Taking a New Path: Evaluating Clinical Data With HER2-Targeted ADCs in Genitourinary, Gastrointestinal, and Gynecological Malignancies
29:36
29:36
Play later
Play later
Lists
Like
Liked
29:36In this episode, Catherine Fahey, MD, PhD; Alexandra Leary, MD, PhD; Funda Meric-Bernstam, MD; and Zev A. Wainberg, MD, explore the mechanisms of HER2-targeted antibody–drug conjugates (ADCs) and emerging clinical data with these agents across genitourinary, gastrointestinal, and gynecologic cancers. Mechanisms of action of ADCs: how ADCs selective…
…
continue reading

1
EGFR-Sparing Anti-HER2 Drug Benefits Patients with Advanced HER2-Mutated Non-Small Cell Lung Cancer
12:59
12:59
Play later
Play later
Lists
Like
Liked
12:59An interview with: John V Heymach MD PhD, Professor and Chair of Thoracic/Head and Neck Medical Oncology, Ruth Legett Jones Distinguished Chair, University of Texas MD Anderson Cancer Center, Houston TX And with: Jayesh Desai MD, Medical Oncologist, Associate Director Clinical Research, Peter MacCallum Cancer Centre, Melbourne, Australia, Co-Chair,…
…
continue reading

1
Neoadjuvant PD-1 Blockade Enables Patients with Mismatch Repair Deficient Colorectal Cancers to Avoid Surgery
14:03
14:03
Play later
Play later
Lists
Like
Liked
14:03An interview with: Andrea Cercek MD, Gastrointestinal Cancer Medical Oncologist, Memorial Sloan Kettering Cancer Center, New York And: Ryan B Corcoran MD PhD, Director of the GI Cancer Program, Massachusetts General Hospital Cancer Center, Boston MA CHICAGO—The Audio Journal of Oncology reports on the neoadjuvant use of programmed cell-death protei…
…
continue reading

1
Topical BRAF-inhibiting Gel Controls Acneiform Rash in Patients with Colorectal Cancer Treated with EGFR-inhibition
8:45
8:45
Play later
Play later
Lists
Like
Liked
8:45An interview with: Anisha B Patel MD, Associate Professor of Dermatology, Division of Internal Medicine, MD Anderson Cancer Center, Houston TX CHICAGO, USA—Acneiform rash toxicities caused by anti- epidermal growth factor receptor (EGFR) therapies were markedly reduced among patients with colorectal cancer in a double-blind placebo-controlled, rand…
…
continue reading

1
Adding Perioperative Pembrolizumab to Standard of Care Improves Outcomes in Patients with Newly Diagnosed Head and Neck Cancers
13:26
13:26
Play later
Play later
Lists
Like
Liked
13:26Interviews with: Ravindra Uppaluri, MD PhD, Director of Head and Neck Surgical Oncology, Dana Farber Brigham Cancer Center, Boston MA; And: Ryan B Corcoran MD PhD, Director of the gastrointestinal cancer program, Massachusetts General Hospital Cancer Center, Associate Professor of Medicine Harvard Medical School and Co-Chair of the American Associa…
…
continue reading

1
Breaking Down Silos: How MPCCC is Transforming Cancer Care
34:25
34:25
Play later
Play later
Lists
Like
Liked
34:25Send us a text Welcome to Episode 29 of The Oncology Podcast's Experts On Point series, brought to you by The Oncology Network. Hosted by Rachael Babin. How do we tackle inequities in cancer care? What role do collaborative networks play in ensuring better outcomes for patients and their families? And how can molecular tumour boards bridge the gap …
…
continue reading

1
RAS Inhibitor Zoldonrasib Brings Clinical Benefit in Patients with G12D Mutated Non-Small Cell Advanced Lung Cancer
12:15
12:15
Play later
Play later
Lists
Like
Liked
12:15An interview with: Kathryn C Arbour MD, Thoracic Medical Oncologist, Memorial Sloan Kettering Cancer Center, New York USA And: Ryan B Corcoran MD PhD, Massachusetts General Cancer Center, Associate Professor of Medicine Harvard Medical School, Co-Chair, American Association for Cancer Research Clinical Trials Committee CHICAGO, USA— The four per ce…
…
continue reading

1
JCO Article Insights: ESPAC4 Long-Term Follow-Up in Pancreatic Cancer
6:47
6:47
Play later
Play later
Lists
Like
Liked
6:47In this JCO Article Insights episode, host Jospeh Mathew summaries Pancreatic Adenocarcinoma: Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial, by Palmer, et al published December 5, 2024. Transcript Joseph Matthew: Hello and welcome to the Journal of Clinical Oncology Article Insights. I'm your host, Joseph Matthew, and today w…
…
continue reading

1
The Latest Evidence on Targeting B7-H3 in Small Cell Lung Cancer
18:34
18:34
Play later
Play later
Lists
Like
Liked
18:34In this episode, hear Lauren Byers, MD and Christine Hann, MD share their insights on the latest data regarding new therapies targeting B7-H3 in small cell lung cancer including: Rationale for targeting B7-H3 Overview of the structure of antibody-drug conjugates (ADCs) Results from the phase I/II IDeate-PanTumor01 trial of ifinatamab deruxtecan (I-…
…
continue reading

1
S3 E3 The Oncology Journal Club Podcast: To INFINITY and Beyond! Rethinking Treatment Paradigms and Common Sense Trial Design
35:08
35:08
Play later
Play later
Lists
Like
Liked
35:08Send us a text Welcome to The Oncology Journal Club Podcast Series 3 Hosted by Professor Craig Underhill, Dr Kate Clarke & Professor Christopher Jackson | Proudly produced by The Oncology Network The Oncology Journal Club team take a deep dive into three standout papers: Craig kicks us off with a timely perspective on the long-term toxicity of immu…
…
continue reading

1
Navigating the Patient's Journey featuring Brenda Snow
57:59
57:59
Play later
Play later
Lists
Like
Liked
57:59Patient Worthy is humbled to speak to Brenda Snow, CEO and Founder of Snow Companies and now the bestselling author of 'Diagnosed: The Essential Guide to Navigating the Patient's Journey'. We discuss Brenda's own journey with Multiple Sclerosis and how she has turned it into a career and guidebook for others facing chronic diagnoses. You can find B…
…
continue reading

1
The Lay of the Land: Overview of Biology of HER2 in Genitourinary, Gastrointestinal, and Gynecologic Malignancies
14:09
14:09
Play later
Play later
Lists
Like
Liked
14:09In this episode, Zev A. Wainberg, MD; Funda Meric-Bernstam, MD; Alexandra Leary, MD, PhD; and Catherine Fahey, MD, PhD, explore testing for HER2 alterations and the incidence of HER2-positive disease in the treatment of genitourinary, gastrointestinal, and gynecologic malignancies. HER2 Testing in Advanced Cancers: Recommendations for when and how …
…
continue reading

1
Managing Eye and Vision Changes Related to Cancer Treatments
57:10
57:10
Play later
Play later
Lists
Like
Liked
57:10- Overview of Common Eye & Vision Changes Related to Cancer Treatments- Discussion of Common Eye & Vision Changes, Including Causes & Risk Factors- Tips to Manage Dry Eyes, Watery Eyes, Itching Eyes, Blepharitis, Loss of Eyelashes, Changes in Vision, Cataracts, Floaters & Flashing Lights- The Role of the Multidisciplinary Team- Tips to Manage Low V…
…
continue reading

1
Trends in Oncology & Treatment Planning: A Guide to Getting the Best Care
56:59
56:59
Play later
Play later
Lists
Like
Liked
56:59- Understanding Your Cancer Diagnosis & Treatment Options- Clinical Trial Opportunities: How Research Increases Treatment Options- Factors That May Affect Treatment Planning- How Your Health Care Team May Help You Address Your Care- Participating in Decisions about Your Treatment Plans, Side Effect Prevention & Management- Understanding the Role of…
…
continue reading

1
Exosome Liquid Biopsy for Earliest Pancreatic Cancer Detection
13:10
13:10
Play later
Play later
Lists
Like
Liked
13:10An interview with: Ajay Goel PhD, Chair of the Molecular Diagnostics and Experimental Therapeutics Department, Beckman Research Institute, City of Hope, Los Angeles California. SAN DIEGO—The prospect of detecting pancreatic cancer at very early stages, when cure may be possible, is now being held out by research showing that the sub-cellular molecu…
…
continue reading

1
Longitudinal Results from the Nationwide Just ASK Initiative to Promote Routine Smoking Assessment
26:50
26:50
Play later
Play later
Lists
Like
Liked
26:50Host Dr. Davide Soldato and guests Dr. Jessica Burris discuss the article "Longitudinal Results from the Nationwide Just ASK Initiative to Promote Routine Smoking Assessment in American College of Surgeons Accredited Cancer Programs" and how persistent smoking following cancer diagnosis causes adverse outcomes while smoking cessation can improve su…
…
continue reading

1
Long Remissions with Bispecific T-cell Engager Antibody Therapy for Patients with Relapsed Multiple Myeloma
15:43
15:43
Play later
Play later
Lists
Like
Liked
15:43An interview with: Sundar Jagannath MBBS, Professor of Medicine, Hematology and Medical Oncology, Director of the Center of Excellence for Multiple Myeloma, Icahn School of Medicine, Mount Sinai, New York. Sarah Maxwell, Audio Journal of Oncology: “An exciting, new immunotherapy treatment for multiple myeloma, was under discussion at the 2024 Ameri…
…
continue reading

1
Personalized Vaccine Brought Durable Immune Responses and Fewer Relapses in Head and Neck Cancers
13:33
13:33
Play later
Play later
Lists
Like
Liked
13:33An interview with: Olivier Lantz MD PhD, Head of the Clinical Immunology Laboratory, Institut Curie, Paris, France PARIS, France—A clinical trial using a personalized therapeutic vaccine, that recognizes multiple genetic features of each patient’s tumor, brought durable tumor-specific immune responses in patients with surgically resected HPV-negati…
…
continue reading
In this JCO Article Insights episode, Lauren Shih summaries "Longitudinal Results From the Nationwide Just ASK Initiative to Promote Routine Smoking Assessment in American College of Surgeons–Accredited Cancer Programs" by Jessica L. Burris, et al published November 19, 2024. Come back for the next episode where JCO After Hours host, Dr. Davide Sol…
…
continue reading

1
Neurofibromatosis Type 1 Plexiform Neurofibromas — An interview with Dr Christopher L Moertel
49:28
49:28
Play later
Play later
Lists
Like
Liked
49:28Dr Christopher L Moertel from the University of Minnesota in Minneapolis discusses the clinical presentation of and optimal management strategies for plexiform neurofibromas and malignancies associated with neurofibromatosis type 1. CME information and select publications here.By Research To Practice
…
continue reading

1
Adding Anthracycline Improved Outcomes for Patients with High-Risk HR-positive, HER2-negative Breast Cancer
7:56
7:56
Play later
Play later
Lists
Like
Liked
7:56SAN ANTONIO, USA—Women with hormone receptor positive HER-2 negative breast cancer and Oncotype DX recurrence scores above 31 could benefit from having anthracycline therapy added to their taxane-based chemotherapy, according to breast medical oncologist and assistant professor of internal medicine, Nan Chen MD, from the University of Chicago. She …
…
continue reading

1
Oncologist On-Call: Thoughts on the Current Treatment Landscape for First-line Management of HER2-Positive mBC
14:42
14:42
Play later
Play later
Lists
Like
Liked
14:42In this episode, listen to Stephanie L. Graff, MD, FACP, FASCO; and Laura M. Spring, MD, share their clinical insights and takeaways regarding the current treatment landscape for first-line treatment of patients with HER2-positive metastatic breast cancer including: Data from multicenter, single-arm, phase IIIb/IV DESTINY-Breast12 evaluating trastu…
…
continue reading

1
S3E2 The Oncology Journal Club Podcast: Is DEI Dead? The Future of Diversity, Equity and Inclusion in Healthcare
38:59
38:59
Play later
Play later
Lists
Like
Liked
38:59Send us a text Welcome to The Oncology Journal Club Podcast Series 3 Hosted by Professor Craig Underhill, Dr Kate Clarke & Professor Christopher Jackson | Proudly produced by The Oncology Network The Oncology Journal Club hosts break from their usual format to discuss the impact of political shifts on diversity, equity and inclusion in cancer resea…
…
continue reading

1
Specific Subgroups of Patients with Metastatic Castration Resistant Prostate Cancer Live Longer with Talazoparib Added to their Enzalutamide Therapy
22:08
22:08
Play later
Play later
Lists
Like
Liked
22:08SAN FRANCISCO, CA—Adding the poly ADP ribose polymerase (PARP) inhibitor drug talazoparib to standard anti-androgen therapy with enzalutamide statistically significantly extended overall survival among patients whose metastatic castration resistant prostate cancers had specific molecular markers. This finding was reported at the 2025 American Socie…
…
continue reading

1
Botensilimab Plus Balstilimab in Advanced Sarcomas
21:00
21:00
Play later
Play later
Lists
Like
Liked
21:00Dr. Shannon Westin and her guest, Dr. Breelyn Wilky, discuss the JCO article, "“Botensilimab (Fc-enhanced anti-cytotoxic lymphocyte-association protein-4 antibody) Plus Balstilimab (anti-PD-1 antibody) in Patients With Relapsed/Refractory Metastatic Sarcomas." TRANSCRIPT Shannon Westin: Hello, everyone, and welcome to another episode of JCO After H…
…
continue reading
- How to Cope While Waiting for Test Results from Cancer Work-Up- Managing Cancer When You Have Other Health Problems- The Impact of Chronic Illness on Cancer Treatment- The Importance of Adherence: Taking Your Treatment on Schedule- Reducing Harmful Drug Interactions- The Role of Clinical Trials: How Research Increases Your Treatment Options- Know…
…
continue reading

1
S3E1 The Oncology Journal Club Podcast: ASCO GI Highlights 2025
46:13
46:13
Play later
Play later
Lists
Like
Liked
46:13Send us a text Welcome to The Oncology Journal Club Podcast Series 3! Proudly produced by The Oncology Network Three respected oncologists dive deep into the most significant research presented at ASCO GI 2025, bringing you practice-changing insights amidst a backdrop of political uncertainty affecting medical research. Professor Chris Karapetis jo…
…
continue reading

1
Patients with Desmoplastic Melanoma Were Exceptional Responders to Single Agent Pembrolizumab
13:37
13:37
Play later
Play later
Lists
Like
Liked
13:37Audio Journal of Oncology Patients with Desmoplastic Melanoma Were Exceptional Responders to Single Agent Pembrolizumab LOS ANGELES, CA—Single agent immunotherapy with the anti-programmed death-1 (PD-1) agent pembrolizumab resulted in markedly high melanoma-specific survival rates among patients with either resectable or metastatic desmoplastic mel…
…
continue reading

1
Understanding the Different Names for Biomarker Testing and Their Role in Selecting the Best Treatment for You
56:49
56:49
Play later
Play later
Lists
Like
Liked
56:49- Overview of the Different Names for Biomarker Testing & Why They Can Be Helpful for Treatment- Tumor Marker Testing, Genomic Profiling, Genomic Sequencing, Molecular Profiling, Next Generation Sequencing- The Relationship Between Biomarker Testing & Precision Medicine- Types of Biomarker Tests for Cancer Treatment- Do I Need Biomarker Testing for…
…
continue reading

1
Understanding the Important Role that Biomarker Testing Plays in Informing the Treatment of Cancer
58:17
58:17
Play later
Play later
Lists
Like
Liked
58:17- Overview & Definition of Biomarkers- What are Some Examples of Biomarker Testing- How Biomarker Testing Provides Useful Information for Cancer Treatment- Why the Molecular Portrait of Cancer is so Important- The Role of the Pathologist- Benefits of Biomarker Testing & Precision Medicine- Predicting Response to Treatment- Clinical Trials: How Rese…
…
continue reading

1
Bilateral Mastectomy and Salpingo-Oophorectomy Significantly Extend Survival In BRCA-mutation Carriers Who Already Have Breast Cancer
13:20
13:20
Play later
Play later
Lists
Like
Liked
13:20Bilateral Mastectomy and Salpingo-Oophorectomy Significantly Extend Survival In BRCA-mutation Carriers Who Already Have Breast Cancer The important question of whether to recommend risk-reducing surgery to patients who are carriers of pathogenic mutations in either BRCA1 or BRCA2 genes (or both), and have already developed breast cancer, has been i…
…
continue reading

1
JCO Article Insights: Long-Term Outcome of Neoadjuvant Chemotherapy for Rectal Cancer
8:47
8:47
Play later
Play later
Lists
Like
Liked
8:47In this JCO Article Insights episode, Peter Li summarizes “Neoadjuvant Modified Infusional Fluorouracil, Leucovorin, and Oxaliplatin With or Without Radiation Versus Fluorouracil Plus Radiation for Locally Advanced Rectal Cancer: Updated Results of the FOWARC Study After a Median Follow-Up of 10 Years,” by Dr. Jianwei Zhang et al. published on Dece…
…
continue reading

1
Expert Insights and FAQs on CDK4/6 Inhibitors in the Care of Today’s Patients With HR-Positive/HER2-Negative Breast Cancer
45:08
45:08
Play later
Play later
Lists
Like
Liked
45:08In this episode, Jame Abraham, MD, FACP; William J. Gradishar, MD, FACP, FASCO; and Laura Spring, MD, review key insights and frequently asked questions related to the CDK4/6 inhibitors used to treat patients with early and metastatic hormone receptor (HR)–positive/HER2-negative breast cancer from a live program held in January 2025. Key clinical p…
…
continue reading

1
Nothing to fear? Facing the challenge of fear of cancer recurrence
49:34
49:34
Play later
Play later
Lists
Like
Liked
49:34Send us a text Confronting the Fear of Cancer Recurrence Welcome to the latest Series of Supportive Care Matters, a podcast hosted by Medical Oncologist and International Cancer Survivorship Expert, Professor Bogda Koczwara AM. The fear of cancer returning is a silent struggle for many survivors, often overshadowing their recovery. In Episode 1 of …
…
continue reading

1
High Omega-3, Low Omega-6 Diet with Fish Oil and Prostate Cancer
12:12
12:12
Play later
Play later
Lists
Like
Liked
12:12Host Dr. Shannon Westin and guests Dr. Bill Aronson discuss the article "High Omega-3, Low Omega-6 Diet With Fish Oil for Men With Prostate Cancer on Active Surveillance: The CAPFISH-3 Randomized Clinical Trial" and how Omega-6 are predominant in the American diet while the study significantly lowered the intake of Omega- 6 fats. TRANSCRIPT Dr. Sha…
…
continue reading

1
Bispecific Antibody Therapy in Relapsed/Refractory Multiple Myeloma: Key Updates From the Annual Hematology Meeting
20:01
20:01
Play later
Play later
Lists
Like
Liked
20:01In this episode, Shaji K. Kumar, MD, reviews key data on bispecific antibodies used to treat patients with relapsed/refractory multiple myeloma recently presented at the 2024 annual American Society of Hematology meeting, including: Early results with teclistamab combined with anti-CD38 therapy Real-world data with teclistamab including its use aft…
…
continue reading

1
Clinical Trials: How They Transform the Treatment of Cancer
55:49
55:49
Play later
Play later
Lists
Like
Liked
55:49- Overview of Clinical Trials & Why They are Important- Understanding Your Treatment Options, Including Clinical Trials- Concerns About Participating in Clinical Trials- Types of Clinical Trials- What Happens in a Clinical Trial?- The Meaning of Informed Consent- Benefits & Risks of Participation- How & Where Clinical Trials are Conducted- How to P…
…
continue reading

1
S2 Ep28: Oncology PER® Spectives™: Oncology Consultations®: Epithelioid Sarcoma: Applying Clinical Updates to Real Patient Cases
29:33
29:33
Play later
Play later
Lists
Like
Liked
29:33By PER® Spectives
…
continue reading

1
S2 Ep27: Oncology PER® Spectives™: Transforming Treatment in Small Cell Lung Cancer: How Recent Trials Are Shaping Treatment Decision Making and Future Therapies
52:01
52:01
Play later
Play later
Lists
Like
Liked
52:01By PER® Spectives
…
continue reading

1
JCO Article Insights: TROPION-Lung01 Dato-DXd in NSCLC
10:21
10:21
Play later
Play later
Lists
Like
Liked
10:21In this JCO Article Insights episode, Ece Cali summarizes findings from the JCO article, "Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study." TRANSCRIPT Ece Cali: Hello and welcome to the JCO Article Insights. I'm your host Ece …
…
continue reading